Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Matsutani, M."" wg kryterium: Autor


Tytuł:
Exploration of Metabolite Biomarkers to Predict the Efficacy of Dupilumab Treatment for Atopic Dermatitis.
Autorzy:
Miyamoto S; Department of Dermatology, Hyogo Medical University, 1-1, Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.; Department of Dermatology Institute of Biomedical Sciences, Tokushima University Graduate School, 2-50-1, Kuramoto-cho, Tokushima, Tokushima 770-8503, Japan.
Imai Y; Department of Dermatology, Hyogo Medical University, 1-1, Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.; Imai Adult and Pediatric Dermatology Clinic, 5-1-1, Ebie, Fukushima-ku, Osaka, Osaka 553-0001, Japan.; Department of Dermatology, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie 514-8507, Japan.
Matsutani M; Department of Dermatology, Hyogo Medical University, 1-1, Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.
Nagai M; Department of Dermatology, Hyogo Medical University, 1-1, Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.
Yamanishi K; Department of Dermatology, Hyogo Medical University, 1-1, Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.; Department of Dermatology, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie 514-8507, Japan.
Kanazawa N; Department of Dermatology, Hyogo Medical University, 1-1, Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.
Nishiumi S; Department of Omics Medicine, Hyogo Medical University, 1-1, Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.; Department of Biosphere Sciences, School of Human Sciences, Kobe College, 4-1, Okadayama, Nishinomiya, Hyogo 662-8505, Japan.
Pokaż więcej
Źródło:
Disease markers [Dis Markers] 2023 Nov 01; Vol. 2023, pp. 9013756. Date of Electronic Publication: 2023 Nov 01 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Dermatitis, Atopic*/drug therapy
Humans ; Retrospective Studies ; Ribose/therapeutic use ; Treatment Outcome ; Severity of Illness Index ; Biomarkers
Czasopismo naukowe
Tytuł:
TFIID dependency of steady-state mRNA transcription altered epigenetically by simultaneous functional loss of Taf1 and Spt3 is Hsp104-dependent.
Autorzy:
Iwami R; Molecular and Cellular Biology Laboratory, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan.
Takai N; Molecular and Cellular Biology Laboratory, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan.
Matsutani M; NODAI Genome Research Center, Tokyo University of Agriculture, Setagaya-ku, Tokyo, Japan.
Shiwa Y; NODAI Genome Research Center, Tokyo University of Agriculture, Setagaya-ku, Tokyo, Japan.; Department of Molecular Microbiology, Faculty of Life Sciences, Tokyo University of Agriculture, Setagaya-ku, Tokyo, Japan.
Kokubo H; Faculty of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Kasahara K; Department of Molecular Microbiology, Faculty of Life Sciences, Tokyo University of Agriculture, Setagaya-ku, Tokyo, Japan.
Kokubo T; Molecular and Cellular Biology Laboratory, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Feb 09; Vol. 18 (2), pp. e0281233. Date of Electronic Publication: 2023 Feb 09 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Saccharomyces cerevisiae Proteins*/metabolism
TATA-Binding Protein Associated Factors*/genetics
Transcription Factor TFIID/genetics ; Saccharomyces cerevisiae/genetics ; Saccharomyces cerevisiae/metabolism ; Transcription, Genetic ; RNA, Messenger/genetics ; TATA-Box Binding Protein/genetics ; Heat-Shock Proteins/genetics ; Transcription Factors/genetics
Czasopismo naukowe
Tytuł:
Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker Study.
Autorzy:
Nagane M; Department of Neurosurgery, Kyorin University Faculty of Medicine, Tokyo 181-8611, Japan.
Ichimura K; Department of Brain Disease Translational Research, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Onuki R; Division of Bioinformatics, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Narushima D; Division of Bioinformatics, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Honda-Kitahara M; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Satomi K; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Tomiyama A; Department of Brain Disease Translational Research, Juntendo University Faculty of Medicine, Tokyo 113-8421, Japan.
Arai Y; Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Shibata T; Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Narita Y; Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Uzuka T; Department of Neurosurgery, Dokkyo Medical University, Tochigi 321-0293, Japan.
Nakamura H; Department of Neurosurgery, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8555, Japan.
Nakada M; Department of Neurosurgery, Graduate School of Medical Sciences, Kanazawa University, Kanazawa 920-1192, Japan.
Arakawa Y; Department of Neurosurgery, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.
Ohnishi T; Department of Neurosurgery, Graduate School of Medicine, Ehime University, Ehime 790-0052, Japan.
Mukasa A; Department of Neurosurgery, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8654, Japan.
Tanaka S; Department of Neurosurgery, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8654, Japan.
Wakabayashi T; Department of Neurosurgery, Graduate School of Medicine, Nagoya University, Aichi 464-8601, Japan.
Aoki T; Department of Neurosurgery, Kyoto Medical Center, Kyoto 612-8555, Japan.
Aoki S; Department of Radiology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.
Shibui S; Department of Neurosurgery, Teikyo University Hospital, Kawasaki 213-8507, Japan.
Matsutani M; Department of Neurosurgery, Kurosawa Hospital, Gunma 370-1203, Japan.
Ishizawa K; Department of Pathology, Saitama Medical University, Saitama 350-0495, Japan.
Yokoo H; Department of Human Pathology, Graduate School of Medicine, Gunma University, Gunma 371-8511, Japan.
Suzuki H; Department of Pathology and Laboratory Medicine, National Hospital Organization Sendai Medical Center, Miyagi 983-8520, Japan.
Morita S; Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.
Kato M; Division of Bioinformatics, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Nishikawa R; Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Saitama 350-1298, Japan.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Nov 10; Vol. 14 (22). Date of Electronic Publication: 2022 Nov 10.
Typ publikacji:
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies